CN103223118B - Traditional Chinese medicine composition for treating facial paralysis - Google Patents
Traditional Chinese medicine composition for treating facial paralysis Download PDFInfo
- Publication number
- CN103223118B CN103223118B CN201310097970.3A CN201310097970A CN103223118B CN 103223118 B CN103223118 B CN 103223118B CN 201310097970 A CN201310097970 A CN 201310097970A CN 103223118 B CN103223118 B CN 103223118B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- facial paralysis
- medicine composition
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 46
- 208000036826 VIIth nerve paralysis Diseases 0.000 title claims abstract description 33
- 208000004929 Facial Paralysis Diseases 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 241001604597 Pyrestini Species 0.000 claims abstract description 10
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims abstract description 9
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 9
- 241000255791 Bombyx Species 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 9
- 241000237636 Pheretima Species 0.000 claims description 9
- 230000000694 effects Effects 0.000 abstract description 25
- 208000002193 Pain Diseases 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 230000036407 pain Effects 0.000 abstract description 8
- 206010010904 Convulsion Diseases 0.000 abstract description 5
- 230000036461 convulsion Effects 0.000 abstract description 5
- 206010007247 Carbuncle Diseases 0.000 abstract description 3
- 241000931705 Cicada Species 0.000 abstract description 2
- 241000255789 Bombyx mori Species 0.000 abstract 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 abstract 1
- 241000208809 Carthamus Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000305491 Gastrodia elata Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 244000280244 Luffa acutangula Species 0.000 abstract 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 208000025747 Rheumatic disease Diseases 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 230000000552 rheumatic effect Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000003447 ipsilateral effect Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 208000031481 Pathologic Constriction Diseases 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000001215 vagina Anatomy 0.000 description 3
- 208000010201 Exanthema Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 208000014337 facial nerve disease Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000007665 sagging Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 208000006373 Bell palsy Diseases 0.000 description 1
- 241000270722 Crocodylidae Species 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 206010015995 Eyelid ptosis Diseases 0.000 description 1
- 206010063006 Facial spasm Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 208000008630 Sialorrhea Diseases 0.000 description 1
- 206010041277 Sodium retention Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 241001125929 Trisopterus luscus Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003872 anastomosis Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- LNNWVNGFPYWNQE-GMIGKAJZSA-N desomorphine Chemical compound C1C2=CC=C(O)C3=C2[C@]24CCN(C)[C@H]1[C@@H]2CCC[C@@H]4O3 LNNWVNGFPYWNQE-GMIGKAJZSA-N 0.000 description 1
- 238000005474 detonation Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 230000008921 facial expression Effects 0.000 description 1
- 210000000109 fascia lata Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000018984 mastication Effects 0.000 description 1
- 238000010077 mastication Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 201000002273 mucopolysaccharidosis II Diseases 0.000 description 1
- 208000022018 mucopolysaccharidosis type 2 Diseases 0.000 description 1
- 230000020763 muscle atrophy Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 201000003004 ptosis Diseases 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating facial paralysis. The traditional Chinese medicine composition for treating the facial paralysis is prepared from the following traditional Chinese medicine raw materials, by weight, 5-20 parts of radix puerariae, 5-25 parts of cassia twig, 5-25 parts of gastrodia elata, 5-20 parts of scutellaria baicalensis, 10-30 parts of radix paeoniae alba, 5-20 parts of rhizoma typhonii, 5-20 parts of stiff silkworm, 5-20 parts of cicada slough, 5-25 parts of hematoxylon, 5-25 parts of cortex erythrinae, 5-15 parts of rhizoma cyperi, 3-10 parts of carthamus tinctorious, 5-25 parts of ligusticum wallichii, 5-20 parts of earthworm, 5-25 parts of loofah sponge, 5-20 parts of fructus arctii, 5-20 parts of dandelions, 5-25 parts of salviae miltiorrhizae, and 5-15 parts of honey-fried licorice root. The traditional Chinese medicine composition for treating the facial paralysis has the effects of clearing heat and relieving rheumatic pains, eliminating carbuncle and relieving convulsion, promoting blood circulation and removing stasis, and dispelling melancholy and eliminating stagnation, and the traditional Chinese medicine composition for treating the facial paralysis is effective in treating the facial paralysis and reliable in effect.
Description
Technical field
The present invention relates to a kind of pharmaceutical product of not determining structure of traditional herbal medicines, especially a kind of Chinese medicine composition of facial paralysis.
Background technology
Facial paralysis, formal name used at school facial paralysis, also claim facial neuritis, bell's palsy, hunter syndrome, be commonly called as " wapperijaw ", " facial paralysis ", " facial neuritis ", " wapperijaw wind " etc., typically refer to caused by a variety of causes non-to carry out abnormal the caused kentrokiness obstacle of nervus facialis be a kind of commonly encountered diseases taking facial expression muscle group dyskinesia as principal character, general symptom is facial hemiparalysis.Patient's face is often the most basic lifts eyebrow, close one's eyes, the drum cheek, the action such as pout one's lips as a signal all cannot complete.Pathogenic factor mostly by face suffer from cold, due to physical injury or poisoning intrusion.Suffering from facial paralysis should treat in time, prevents that the state of an illness from deepening and occur the clinical manifestations such as conduction neural impulse extensive situation, existing crocodile tear disease and mouthful eye interlock, and some patients were also can secondary Ipsilateral facial spasm, further can develop into denervated muscle atrophy.
The method of existing facial paralysis treatment has Drug therapy and two kinds of methods of surgical operation therapy.Doctor trained in Western medicine is advocated early stage application antiviral, trophic nerve, glucocorticoid, is improved the Drug therapy of blood circulation.If but too much application antibiotic easily produces a lot of side effect and retroaction, make the appearance of the symptoms such as facial paralysis patient immunity degradation, slow, the fertile swollen difficulty of recovery are divided, water-sodium retention.Surgical operation therapy can be divided into dynamic property treatment and static treatment.Static treatment is mainly that fascia lata is transplanted into strips in face; The treatment of dynamic facial paralysis was generally divided into for 2 phases, first phase is nerve and the neural anastomosis of strong side of taking off from patient's Ipsilateral shank, Nerve Graft tip is placed in Ipsilateral, afterwards after half a year to one year, nerve can be grown into Ipsilateral from strong side, come into effect the operation of the second phase, transplanting the muscle with nervus vasculairs.Surgical operation therapy risk is large and expense is high.
Motherland's traditional medicine thinks, facial paralysis often, due to overwork, nervous, depressed, causes human righteousness's deficiency, and the heresy of wind and cold is taken advantage of a weak point.Control suitable dispelling pathogenic wind and eliminating phlegm, relieving spasm by subduing liver-wind, promoting blood circulation to remove obstruction in the collateral.
According to theory of Chinese medical science, for the pathogeny of facial paralysis, carry out dialectical composition of prescription, to reach the object for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome antibiotic therapy facial paralysis in prior art and surgical operation therapy facial paralysis has a big risk, expense is high deficiency, the invention provides a kind of prepare easy, cost is low, the Chinese medicine composition of evident in efficacy, the facial paralysis that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition of facial paralysis, it is characterized in that: it is to be made up of the raw material of Chinese medicine of following weight portion: Radix Puerariae 5-20 part, Ramulus Cinnamomi 5-25 part, Rhizoma Gastrodiae 5-25 part, Radix Scutellariae 5-20 part, Radix Paeoniae Alba 10-30 part, Rhizoma Typhonii 5-20 part, Bombyx Batryticatus 5-20 part, Periostracum Cicadae 5-20 part, Lignum Sappan 5-25 part, Cortex erythrinae 5-25 part, Rhizoma Cyperi 5-15 part, Flos Carthami 3-10 part, Rhizoma Chuanxiong 5-25 part, Pheretima 5-20 part, Retinervus Luffae Fructus 5-25 part, Fructus Arctii 5-20 part, Herba Taraxaci 5-20 part, Radix Salviae Miltiorrhizae 5-25 part, Radix Glycyrrhizae Preparata 5-15 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition of facial paralysis, is characterized in that: it is to be made up of the raw material of Chinese medicine of following weight portion: 12 parts of Radix Puerariaes, 15 parts of Ramulus Cinnamomi, 15 parts, Rhizoma Gastrodiae, 12 parts of Radix Scutellariaes, 20 parts of the Radix Paeoniae Albas, 10 parts of Rhizoma Typhoniis, 10 parts of Bombyx Batryticatus, 10 parts of Periostracum Cicadaes, 15 parts of Lignum Sappans, 15 parts of Cortex erythrinaes, 9 parts of Rhizoma Cyperis, 5 parts, Flos Carthami, 15 parts of Rhizoma Chuanxiongs, 10 parts of Pheretimas, 15 parts of Retinervus Luffae Fructuss, 10 parts of Fructus Arctiis, 10 parts of Herba Taraxacis, 15 parts of Radix Salviae Miltiorrhizaes, 8 parts of Radix Glycyrrhizae Preparatas.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In Chinese medicine composition of the present invention: Radix Puerariae has relieving muscles diaphoresis, invigorating YANG QI to promote eruption, antipyretic effect of promoting the production of body fluid; Ramulus Cinnamomi has effect of diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation, supporing yang activating QI, dispersing cold for relieving pain; Rhizoma Gastrodiae has effect of endogenous wind stopping relieving convulsion, suppressing the hyperactive liver and subsiding YANG, dispelling wind and removing obstruction in the collateral; Radix Scutellariae has effect of heat clearing and damp drying, eliminating fire and detoxication; The Radix Paeoniae Alba has effect of nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing receipts antiperspirant; Rhizoma Typhonii has that the expectorant that dispels the wind, arresting convulsion are jerked, effect of detoxicating and resolving stagnation of pathogens pain relieving; Bombyx Batryticatus has effect of expelling wind for relieving convulsion, dissipating phlegm and resolving masses; Periostracum Cicadae has effect of loose wind heat extraction, rash sore-throat relieving, nebula removing spasmolytic; Lignum Sappan has effect of promoting the circulation of blood blood stasis dispelling, reducing swelling and alleviating pain; Cortex erythrinae has effect of wind-damp dispelling, channels sootheing and network vessel quickening; Rhizoma Cyperi has effect of the resolving depression of regulating the flow of vital energy, menstruction regulating and pain relieving; Flos Carthami has effect of promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain; Rhizoma Chuanxiong has effect of blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, wind-expelling pain-stopping; Pheretima has effect of clearing heat for calming endogenous wind, lung-clearing asthma-relieving, inducing diuresis for treating stranguria syndrome, current meridians; Effect that Retinervus Luffae Fructus has dredging collateral, invigorates blood circulation, dispels the wind; Fructus Arctii has effect of dispelling wind and heat pathogens, lung qi dispersing rash, resolving toxin and disinhibiting the throat; Herba Taraxaci has effect of heat-clearing and toxic substances removing, dispersing swelling and dissipating binds; Radix Salviae Miltiorrhizae has effect of promoting blood flow to regulate menstruation, blood stasis dispelling eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind; Radix Glycyrrhizae Preparata has effect of spleen reinforcing stomach function regulating, Yiqi and vein recovery.The selected medicament composing prescription of the present invention, its drug component is through dialectical compatibility, helps using mutual assistant, plays altogether effect of clearing away heat and expelling wind, eliminating carbuncle relieving convulsion, blood circulation promoting and blood stasis dispelling, resolving depression eliminating stagnation, and the treatment of facial paralysis is reached to treating both the principal and secondary aspects of a disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, cost is low.The present invention follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopt the use that is decocted in water for oral dose.Through clinical practice checking, it is evident in efficacy reliable, and the property of medicine is gentle, does not occur toxic and side effects, and effective percentage reaches 91.1%, cure rate 68.9%.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
A Chinese medicine composition for facial paralysis, it is to be made up of the raw material of Chinese medicine of following weight proportion: Radix Puerariae 12g, Ramulus Cinnamomi 15g, Rhizoma Gastrodiae 15g, Radix Scutellariae 12g, Radix Paeoniae Alba 20g, Rhizoma Typhonii 10g, Bombyx Batryticatus 10g, Periostracum Cicadae 10g, Lignum Sappan 15g, Cortex erythrinae 15g, Rhizoma Cyperi 9g, Flos Carthami 5g, Rhizoma Chuanxiong 15g, Pheretima 10g, Retinervus Luffae Fructus 15g, Fructus Arctii 10g, Herba Taraxaci 10g, Radix Salviae Miltiorrhizae 15g, Radix Glycyrrhizae Preparata 8g.
Embodiment 2
A Chinese medicine composition for facial paralysis, it is to be made up of the raw material of Chinese medicine of following weight proportion: Radix Puerariae 20g, Ramulus Cinnamomi 5g, Rhizoma Gastrodiae 10g, Radix Scutellariae 15g, Radix Paeoniae Alba 10g, Rhizoma Typhonii 5g, Bombyx Batryticatus 20g, Periostracum Cicadae 15g, Lignum Sappan 10g, Cortex erythrinae 5g, Rhizoma Cyperi 15g, Flos Carthami 10g, Rhizoma Chuanxiong 10g, Pheretima 12g, Retinervus Luffae Fructus 20g, Fructus Arctii 5g, Herba Taraxaci 12g, Radix Salviae Miltiorrhizae 10g, Radix Glycyrrhizae Preparata 5g.
Embodiment 3
A Chinese medicine composition for facial paralysis, it is to be made up of the raw material of Chinese medicine of following weight proportion: Radix Puerariae 15g, Ramulus Cinnamomi 10g, Rhizoma Gastrodiae 25g, Radix Scutellariae 5g, Radix Paeoniae Alba 30g, Rhizoma Typhonii 10g, Bombyx Batryticatus 15g, Periostracum Cicadae 20g, Lignum Sappan 5g, Cortex erythrinae 20g, Rhizoma Cyperi 10g, Flos Carthami 3g, Rhizoma Chuanxiong 25g, Pheretima 5g, Retinervus Luffae Fructus 10g, Fructus Arctii 20g, Herba Taraxaci 8g, Radix Salviae Miltiorrhizae 5g, Radix Glycyrrhizae Preparata 10g.
Embodiment 4
A Chinese medicine composition for facial paralysis, it is to be made up of the raw material of Chinese medicine of following weight proportion: Radix Puerariae 5g, Ramulus Cinnamomi 25g, Rhizoma Gastrodiae 20g, Radix Scutellariae 10g, Radix Paeoniae Alba 15g, Rhizoma Typhonii 20g, Bombyx Batryticatus 5g, Periostracum Cicadae 12g, Lignum Sappan 25g, Cortex erythrinae 10g, Rhizoma Cyperi 5g, Flos Carthami 6g, Rhizoma Chuanxiong 12g, Pheretima 20g, Retinervus Luffae Fructus 5g, Fructus Arctii 15g, Herba Taraxaci 20g, Radix Salviae Miltiorrhizae 25g, Radix Glycyrrhizae Preparata 12g.
Embodiment 5
A Chinese medicine composition for facial paralysis, it is to be made up of the raw material of Chinese medicine of following weight proportion: Radix Puerariae 10g, Ramulus Cinnamomi 12g, Rhizoma Gastrodiae 5g, Radix Scutellariae 20g, Radix Paeoniae Alba 25g, Rhizoma Typhonii 15g, Bombyx Batryticatus 12g, Periostracum Cicadae 5g, Lignum Sappan 20g, Cortex erythrinae 25g, Rhizoma Cyperi 12g, Flos Carthami 8g, Rhizoma Chuanxiong 5g, Pheretima 15g, Retinervus Luffae Fructus 25g, Fructus Arctii 12g, Herba Taraxaci 5g, Radix Salviae Miltiorrhizae 20g, Radix Glycyrrhizae Preparata 15g.
Chinese medicine composition in embodiment of the present invention decocting method is routinely produced medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, adds cold water and cover powder, soak 15～20 minutes, then add water and do not have approximately 6 centimetres of powder, decoct, adopt intense fire to decoct before at a simmer, after boiling with slow fire boiling 20～30 minutes; Second decocts, and add water and do not have powder approximately, 4 centimetres, decoct, after boiling, water decocts 15～20 minutes.Decoct extracting juice twice, merge.
A Chinese medicine composition for facial paralysis, clinical efficacy is summed up:
One, general data: this Chinese medicine composition is applied to clinical observation case 45 examples, 15～70 years old age.Average 41.3 years old; The course of disease is the shortest 1 day,, the longest 1 month.
Two, diagnostic criteria:
1, mostly be onset unexpected, while waking up in the morning, find that a side surface part is stiff, numb, lax, can not knit one's brows, frown, grinningly, the action such as bulging cheek;
2, ptosis of labial angle slants tiltedly to strong, and nasolabial fold is smooth, talks, cries and be more obvious when laughing at or moving grinningly; The gas leakage of the drum cheek, detonation distorsion difficulty; Feed can have the bicker phenomenon of leakage;
3, some patients were can have sleeping with eyes half-closed to shed tears, volume stricture of vagina disappear, from the beginning of time can have after ear, under ear or face ache.
Three, usage and dosage: when clinical practice, the component in compositions is taken the circumstances into consideration increase and decrease according to patient's body weight and age.Potion on the one, the about 300ml of twice extracting juice of decocting, point morning, evening take for twice.It within five days, is a course for the treatment of.Avoid pungent stimulation food.As Chinese liquor, Bulbus Allii, seafood, strong tea, spicy hot chafing dish etc.
Three, criterion of therapeutical effect:
1, recovery from illness: volume stricture of vagina is deepened, eye is closed normal, and bicker is not sagging, and the drum cheek is air tight, had normal mastication, Ipsilateral is not detained food, not sialorrhea, nasolabial fold bilateral almost symmetry;
2, take a turn for the better: volume stricture of vagina is deepened before, and eye can be closed, but closure is not tight, and bicker is slightly sagging, the air tight or slightly gas leakage of the drum cheek, nasolabial fold before deepens, strong before chewing, suffers from indigestion once in a while;
3, invalid: above symptom is all without obviously changing.
Four, therapeutic effect:
In this clinical observation case, take medicine 1-5 the course for the treatment of, recovery from illness 31 examples, follow up a case by regular visits to and have no recurrence; 10 examples that take a turn for the better, invalid 4 examples.During treatment, there is not toxic and side effects.
Five, model case:
Case 1:
Chen, female, 29 years old.Left side facial paralysis 1 month, has a meal and all cannot chew.Take 1 course for the treatment of of medicament prepared by Chinese medicine composition of the present invention, facial function is recovered with feeling to start; Continue to take 1 course of therapy, lift in left side, closes one's eyes, rouses the cheek, shows tooth, the rehabilitation substantially of each side function.Continue to take 2 courses for the treatment of, symptomatology disappears, and cures.
Case 2:
Week certain, female, 35 years old, left side facial paralysis 3 weeks, the two temples pain of companion, bitter taste is dizzy.Examine and see: light red tongue yellow fur, stringy and tense pulse. take 2 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, transference cure, cures completely, so far without recurrence.
Claims (1)
1. a Chinese medicine composition for facial paralysis, is characterized in that: it is to be made up of the raw material of Chinese medicine of following weight proportion: Radix Puerariae 12g, Ramulus Cinnamomi 15g, Rhizoma Gastrodiae 15g, Radix Scutellariae 12g, Radix Paeoniae Alba 20g, Rhizoma Typhonii 10g, Bombyx Batryticatus 10g, Periostracum Cicadae 10g, Lignum Sappan 15g, Cortex erythrinae 15g, Rhizoma Cyperi 9g, Flos Carthami 5g, Rhizoma Chuanxiong 15g, Pheretima 10g, Retinervus Luffae Fructus 15g, Fructus Arctii 10g, Herba Taraxaci 10g, Radix Salviae Miltiorrhizae 15g, Radix Glycyrrhizae Preparata 8g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310097970.3A CN103223118B (en) | 2013-03-26 | 2013-03-26 | Traditional Chinese medicine composition for treating facial paralysis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310097970.3A CN103223118B (en) | 2013-03-26 | 2013-03-26 | Traditional Chinese medicine composition for treating facial paralysis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103223118A CN103223118A (en) | 2013-07-31 |
| CN103223118B true CN103223118B (en) | 2014-12-03 |
Family
ID=48833914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310097970.3A Expired - Fee Related CN103223118B (en) | 2013-03-26 | 2013-03-26 | Traditional Chinese medicine composition for treating facial paralysis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103223118B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103656587B (en) * | 2013-12-13 | 2015-05-13 | 徐士魁 | Medicine for treating facial neuritis and preparation method thereof |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104547352A (en) * | 2015-01-27 | 2015-04-29 | 张小凤 | Pharmaceutical composition for treating facioplegia |
| CN104758506A (en) * | 2015-04-08 | 2015-07-08 | 吕院华 | Traditional Chinese medicine for treating facial paralysis |
| CN105079607A (en) * | 2015-09-25 | 2015-11-25 | 冷国玉 | Traditional Chinese medicine composition for treating facial paralysis |
| CN105944021A (en) * | 2016-06-17 | 2016-09-21 | 刘婧 | Plaster for treating facial paralysis |
| CN106421610A (en) * | 2016-11-15 | 2017-02-22 | 常万生 | Traditional Chinese medicine for treating facial paralysis and for neurology department |
-
2013
- 2013-03-26 CN CN201310097970.3A patent/CN103223118B/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103656587B (en) * | 2013-12-13 | 2015-05-13 | 徐士魁 | Medicine for treating facial neuritis and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103223118A (en) | 2013-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103223118B (en) | Traditional Chinese medicine composition for treating facial paralysis | |
| CN103386008A (en) | Chinese medicine composition for treating endocrine dyscrasia | |
| CN102988672B (en) | Traditional Chinese medicine composition for treating irregular menstruation | |
| CN102872381B (en) | Traditional Chinese medicine composition for treating epidemic parotitis | |
| CN103432559B (en) | Traditional Chinese medicine composition for treating spanomenorrhea and dysmenorrhea caused by blood stasis and preparation method and application thereof | |
| CN103479929A (en) | Traditional Chinese medicine composition for treating pruritus | |
| CN104043087A (en) | Traditional Chinese medicine composition for treating Raynaud syndrome | |
| CN103211962B (en) | Chinese medicinal composition for treating anhypnia | |
| CN102512552B (en) | Traditional Chinese medicine composition for treating exogenous fever | |
| CN102526459B (en) | Traditional Chinese medicine composition for treating nasosinusitis and preparation method thereof | |
| CN102302733B (en) | Oral Chinese medicinal composition for treating ovarian cyst | |
| CN103550549B (en) | A kind of Chinese medicine composition for the treatment of deficiency of heart-yin | |
| CN104606514A (en) | Traditional Chinese medicine composition for treating kidney deficiency type tinnitus | |
| CN102416146B (en) | Chinese medicinal composition for treating amenorrhea | |
| CN104623536A (en) | Chinese medicinal combination for treating insomnia | |
| CN104042925A (en) | Traditional Chinese medicinal composition for treating gout and preparation method thereof | |
| CN102988804A (en) | Chinese medicine composition for treating wind-heat type common cold | |
| CN102349957A (en) | Traditional Chinese medicine composition for treating prurigo | |
| CN103816493B (en) | A kind of Chinese medicine composition treating instability of kidney QI | |
| CN105749167A (en) | Traditional Chinese medicine composition for treating amenorrhea | |
| CN105521175A (en) | Traditional Chinese medicine for treating blood stasis type hypomenorrhea | |
| CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
| CN104173932A (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN104147573A (en) | Heat clearing and toxin removing preparation for treating wind-induced headache | |
| CN102784256B (en) | Chinese medicine composition for treating arthralgia-synadrome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: WANG DONGLI Free format text: FORMER OWNER: SUN SHENGBO Effective date: 20141024 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wang Dongli Inventor after: Sun Shengbo Inventor before: Sun Shengbo |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: SUN SHENGBO TO: WANG DONGLI SUN SHENGBO |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20141024 Address after: 264300 Shandong city of Weihai province Rongcheng Chengshan Avenue East No. 101 (Rongcheng City Hospital) Applicant after: Wang Dongli Address before: 264300 Rongcheng City, Shandong Province Cultural East Road, No. 20, No. Applicant before: Sun Shengbo |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141203 Termination date: 20150326 |
|
| EXPY | Termination of patent right or utility model |